ATH

Alpha Transform Holdings Joins SHIB Doggy DAO Foundation as Advisor

Retrieved on: 
星期一, 八月 14, 2023
Ethereum, Tether, Treasury, DAO, M&E, Blockchain, News Corp, ATH, Investment, GEORGE, Disney Media and Entertainment Distribution, Initial public offering, Shiba, Economics, Cryptocurrency, Shiba Inu, The Walt Disney Company

GEORGE TOWN, CAYMAN ISLANDS, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Leading digital asset advisory and investment firm Alpha Transform Holdings (ATH) today announced that it will be advising the foundation behind SHIB Doggy DAO, the decentralized autonomous organization governed by Shiba Inu token holders that funds the projects now being built on the Shibarium blockchain.

Key Points: 
  • GEORGE TOWN, CAYMAN ISLANDS, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Leading digital asset advisory and investment firm Alpha Transform Holdings (ATH) today announced that it will be advising the foundation behind SHIB Doggy DAO, the decentralized autonomous organization governed by Shiba Inu token holders that funds the projects now being built on the Shibarium blockchain.
  • The Shiba Inu ecosystem is one of the first to offer a 360 strategy for M&E integration at scale.
  • We look forward to working with their team as this next era begins,” said Seth Shapiro, Partner, Media and Entertainment, Alpha Transform Holdings.
  • “Shiba Inu has been one of the most exciting and popular tokens in cryptocurrency and we look forward to helping both the Shibarium blockchain and Doggy DAO continue this momentum as the Shiba Inu Ecosystem moves into full-fledged governance,” said Alpha Transform Holdings General Partner Michael Terpin.

Appendix 4C – Q4 FY23 Quarterly Cash Flow Report

Retrieved on: 
星期一, 七月 31, 2023
Multiple system atrophy, Gait, Data monitoring committee, Pathology, American Academy, ASX, Biomarker, ATH, HIV disease progression rates, MSA, Physician, SAN, United Kingdom, Disability studies, Biomusic, DMC, Safety, Disease, Pharmaceutical industry, Medical imaging, Alterity

MELBOURNE, Australia and SAN FRANCISCO, July 31, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, releases its Appendix 4C Quarterly Cash Flow Report and update on company activities for the quarter ending 30 June 2023 (Q4 FY23).

Key Points: 
  • MELBOURNE, Australia and SAN FRANCISCO, July 31, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, releases its Appendix 4C Quarterly Cash Flow Report and update on company activities for the quarter ending 30 June 2023 (Q4 FY23).
  • Importantly, this Biomarker study gives us the opportunity to get an early indication of efficacy before the ATH434-201 Phase 2 study reads out.
  • Individuals with more advanced MSA may also benefit from ATH434 and measuring key biomarkers will permit us to evaluate drug activity in this population.
  • The Company’s cash position on 30 June 2023 was A$15.8M with operating cash outflows for the quarter of A$6.2M.

Bitget's Native Token BGB to Be Listed on MEXC, Ushering in Heights of Price and Liquidity

Retrieved on: 
星期五, 七月 28, 2023
Crypto, Decentralized finance, Launch pad, Burn, BGB, ATH, USDT, Traction, Ministry of National Education (France), Ecosystem, BTC, ROI, Cryptocurrency, Bitget

This strategic move is expected to further boost liquidity, accessibility, and the overall value and utility of the BGB token.

Key Points: 
  • This strategic move is expected to further boost liquidity, accessibility, and the overall value and utility of the BGB token.
  • With a circulating supply of 1,400,000,000 BGB and a total supply of 2,000,000,000, BGB plays a pivotal role in Bitget's ecosystem.
  • BGB experienced significant price growth, reaching an all-time high of over 0.51 USDT in February and was the best-performing exchange token in H1 2023, outpacing BTC.
  • This feature offers eligible BGB holders the opportunity to receive airdrops of any new crypto assets listed on the Bitget platform.

Bitget's Native Token BGB to Be Listed on MEXC, Ushering in Heights of Price and Liquidity

Retrieved on: 
星期五, 七月 28, 2023
Crypto, Decentralized finance, Launch pad, Burn, BGB, ATH, USDT, Traction, Ministry of National Education (France), Ecosystem, BTC, ROI, Cryptocurrency, Bitget

This strategic move is expected to further boost liquidity, accessibility, and the overall value and utility of the BGB token.

Key Points: 
  • This strategic move is expected to further boost liquidity, accessibility, and the overall value and utility of the BGB token.
  • With a circulating supply of 1,400,000,000 BGB and a total supply of 2,000,000,000, BGB plays a pivotal role in Bitget's ecosystem.
  • BGB experienced significant price growth, reaching an all-time high of over 0.51 USDT in February and was the best-performing exchange token in H1 2023, outpacing BTC.
  • This feature offers eligible BGB holders the opportunity to receive airdrops of any new crypto assets listed on the Bitget platform.

EVERTEC Reports Second Quarter 2023 Results

Retrieved on: 
星期三, 七月 26, 2023
Internet, Payments, Finance, Banking, Professional Services, Technology, Electronic Commerce, Fintech, Share repurchase, Banco Popular, GAAP, Sale, Public expenditure, BBR, ATH, EBITDA, Webcast, Growth, NYSE, LATAM, Rare-earth element, Adjustment

EVERTEC, Inc. (NYSE: EVTC) (“Evertec”, the “Company”, “we” or “our”) today announced results for the second quarter ended June 30, 2023.

Key Points: 
  • EVERTEC, Inc. (NYSE: EVTC) (“Evertec”, the “Company”, “we” or “our”) today announced results for the second quarter ended June 30, 2023.
  • Payment processing LATAM revenue growth reflected the impact from the BBR and paySmart acquisitions completed in the third quarter of 2022 and first quarter of 2023, respectively, and organic growth.
  • For the quarter ended June 30, 2023, Adjusted EBITDA was $74 million, a decrease of $0.4 million when compared to the prior year quarter.
  • The Company will host a conference call to discuss its second quarter 2023 financial results today at 4:30 p.m.

Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned

Retrieved on: 
星期三, 七月 26, 2023
Neurodegenerative disease, Food and Drug Administration, Clinical trial, Neuroimaging, Pathology, Pharmacokinetics, ASX, Biomarker, ATH, Patient, MSA, SAN, Data monitoring committee, Therapy, DMC, Food, Safety, Disease, Pharmaceutical industry, Alterity

MELBOURNE, Australia and SAN FRANCISCO, July 26, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an independent Data Monitoring Committee (DMC) recommended the ATH434-201 Phase 2 study continue as planned. The ATH434-201 clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage multiple system atrophy (MSA), a rare neurodegenerative disease with no approved treatments to slow or stop its progression.

Key Points: 
  • MELBOURNE, Australia and SAN FRANCISCO, July 26, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an independent Data Monitoring Committee (DMC) recommended the ATH434-201 Phase 2 study continue as planned.
  • The DMC conducted a prespecified review of unblinded clinical data from an initial cohort of study participants.
  • “The recommendation to continue the Phase 2 trial as planned marks another significant advance in the development of ATH434 for this devastating condition,” said David Stamler, M.D., Chief Executive Officer of Alterity.
  • Additional information on the Phase 2 trial can be found by ClinicalTrials.gov Identifier: NCT05109091 .

Landwolf Token: Epic Launch Marks the Rise of a New Meme

Retrieved on: 
星期五, 七月 21, 2023
Friends, Attention, Movement, ATH, Trust, Growth, Pepe, Social media, Cryptocurrency

With an explosive launch that has left investors and enthusiasts awestruck, Landwolf has swiftly become a force to be reckoned with.

Key Points: 
  • With an explosive launch that has left investors and enthusiasts awestruck, Landwolf has swiftly become a force to be reckoned with.
  • This article delves into the highlights of Landwolf's epic debut, showcasing its rise to prominence and the dawning of a new era in meme culture.
  • From the moment of its inception, Landwolf token has captured the attention of investors and enthusiasts alike.
  • The rise of Landwolf symbolizes a new chapter in meme culture, promising exciting opportunities and captivating moments for those who dare to join this groundbreaking movement.

Bitget Sees Second-Highest Increase in Market Shares and 80% Jump in BGB Volume in Q2

Retrieved on: 
星期二, 七月 18, 2023
Crypto, Blockchain, FTX, Cryptocurrency, CEX, Attention, Fridtjof Nansen, Address, BGB, ATH, Traction, Transparency report, BTC, Liquid, CeX (company), Quarter, Bitcoin, Q2, Bitget, Binance, Coinbase

VICTORIA, Seychelles, July 18, 2023 /PRNewswire/ -- Bitget, top crypto derivatives and copy trading platform, has released its quarterly Transparency Report, highlighting the major achievements of the platform for Q2 of 2023. The report emphasizes Bitget's exceptional performance in increasing market share, trading volumes, token performance, security, and financial solvency, surpassing other prominent exchanges amidst the general market decline.

Key Points: 
  • -          Among the Top 5 CEXs, Bitget had the second-highest increase in market shares, growing by 1.81% to reach 8.7%.
  • -          BGB token became the best-performing CEX token in 2023 with an 80% surge in trading volume, outperforming BTC year-to-date;
    -          Bitget was the only CEX to increase its futures trading volume in 2023 following the FTX collapse.
  • According to the TokenInsight Crypto Exchange Report 2023 Q2 , Bitget ranked among the Top 4 exchanges, collectively accounting for over 85% of the total market.
  • In the spot market, Bitget doubled its market share to 6% in Q2.

Bitget Sees Second-Highest Increase in Market Shares and 80% Jump in BGB Volume in Q2

Retrieved on: 
星期二, 七月 18, 2023
Crypto, Blockchain, FTX, Cryptocurrency, CEX, Attention, Fridtjof Nansen, Address, BGB, ATH, Traction, Transparency report, BTC, Liquid, CeX (company), Quarter, Bitcoin, Q2, Bitget, Binance, Coinbase

VICTORIA, Seychelles, July 18, 2023 /PRNewswire/ -- Bitget, top crypto derivatives and copy trading platform, has released its quarterly Transparency Report, highlighting the major achievements of the platform for Q2 of 2023. The report emphasizes Bitget's exceptional performance in increasing market share, trading volumes, token performance, security, and financial solvency, surpassing other prominent exchanges amidst the general market decline.

Key Points: 
  • -          Among the Top 5 CEXs, Bitget had the second-highest increase in market shares, growing by 1.81% to reach 8.7%.
  • -          BGB token became the best-performing CEX token in 2023 with an 80% surge in trading volume, outperforming BTC year-to-date;
    -          Bitget was the only CEX to increase its futures trading volume in 2023 following the FTX collapse.
  • According to the TokenInsight Crypto Exchange Report 2023 Q2 , Bitget ranked among the Top 4 exchanges, collectively accounting for over 85% of the total market.
  • In the spot market, Bitget doubled its market share to 6% in Q2.

$TET Listing Soars as SoftNote Introduces Live Staking and Bitcoin SoftNote System

Retrieved on: 
星期一, 七月 10, 2023
Blockchain, TEC, Life, Softnotes, Privacy, Commercial software, ATH, Traction, Growth, Ecosystem, DEX, TET, ROI, APY, Cryptocurrency, Online shopping, Bitcoin

Powered by Tectum, SoftNote introduces a fully backed and redeemable cash system, enabling seamless real-world transactions and rewarding users in the process.

Key Points: 
  • Powered by Tectum, SoftNote introduces a fully backed and redeemable cash system, enabling seamless real-world transactions and rewarding users in the process.
  • The SoftNote system offers simplicity, security, and privacy, making it an ideal solution for Bitcoin scaling.
  • With a focus on enhancing user experience and expanding its ecosystem, SoftNote introduces live staking opportunities, the launch of the Bitcoin SoftNote system, and an ongoing airdrop campaign.
  • SoftNote proudly launches the Bitcoin SoftNote system, bringing unprecedented scalability and efficiency to Bitcoin transactions.